WOODCLIFF LAKE, NJ - Barr Pharmaceuticals Inc. announced in a press release that it has initiated a patent challenge for Sanofi-Aventis US LLC's Ambien CR ...
Barr filed its Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for a generic Ambien CR product with the US Food & Drug ...